<DOC>
	<DOCNO>NCT00838669</DOCNO>
	<brief_summary>The purpose study evaluate effect food pharmacokinetics extended-release ( ER ) OROS paliperidone healthy men , evaluate effect posture pharmacokinetics ER OROS paliperidone fast condition . Additionally , safety tolerability treatment healthy men assess .</brief_summary>
	<brief_title>A Study Effect Food Posture Pharmacokinetics Single Dose ER OROS Paliperidone</brief_title>
	<detailed_description>The current study design evaluate effect food pharmacokinetics market formulation ER OROS paliperidone mobile healthy men , represent normal condition . The 12-mg ER OROS paliperidone ER oral administration single dose use study require prolonged bed rest precautionary measure prevent orthostatic hypotension . To support evaluation effect posture pharmacokinetics ER OROS paliperidone fasting condition , study medication also administer healthy men fast state confine bed approximately 36 hour . The safety tolerability treatment healthy men assess . 12 mg ER OROS paliperidone ER , oral administration , single dose</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<criteria>Body mass index ( weight [ kg ] /height [ m2 ] ) 18 30 kg/m2 , inclusive A supine ( 5 minute rest ) blood pressure 100 140 mmHg systolic , inclusive , 50 90 mmHg diastolic , inclusive Healthy basis prestudy physical examination , medical history , 12lead ECG , laboratory result serum chemistry , hematology , urinalysis perform within 21 day first dose . If result serum chemistry , hematology , urinalysis test within laboratory 's reference range , male volunteer include investigator judge deviation clinically significant . For renal function test , value must within normal laboratory reference range . Known drug allergy risperidone , paliperidone , excipients Known history druginduced dystonia Known allergy history significant hypersensitivity heparin , heparin lock use Recent history alcohol substance abuse , positive test result urine drug screen screen upon admittance test facility , positive result alcohol urine test upon admittance test facility Relevant history presence cardiovascular ( include myocardial infarct cardiac arrhythmia ) , respiratory , neurologic ( include seizure ) , psychiatric , renal , hepatic , gastrointestinal ( include surgery , severe gastrointestinal narrowing , malabsorption problem ) , endocrine , hematologic , immunologic disease History cancer , exception basal cell carcinomas History smoking use nicotinecontaining substance within last 2 month , determine medical history and/or volunteer 's verbal report . Volunteers must agree refrain use throughout study</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Mood disorder</keyword>
	<keyword>Antipsychotic drug</keyword>
	<keyword>Extended release OROS paliperidone</keyword>
</DOC>